Marketing Thru Marijuana: Differentiate or Die

MJ Slaps

This is the year that hippie cannabis dies. Woodstock is 50, and has just licensed its name to mega-retailer MedMen.  Hemp is newly de-scheduled and igniting the imaginations of farmers and investors excited about the global opportunity.  Pot Culture has become Pop Culture as legalization has spread coast-to-coast and pushed marijuana into the mainstream. For grassroots marketers who Read the full article…

Tilray Signs Global Collaboration Agreement With Leading Pharmaceutical Company

working-at-sandoz

CANADA: Tilray Canada, a subsidiary of Tilray, a global pioneer in the production, research, and distribution of medical cannabis, announced today that it entered into a global framework agreement to collaborate with C, a global leader in generic pharmaceuticals and biosimilars and a part of Novartis group, to increase availability of high quality medical cannabis products Read the full article…

The Industries Most Impacted By The Legalization Of Cannabis

indoor grow

By Trevor McDonald For an industry that’s still relatively new, we’ve seen some amazing success stories come directly from cannabis sales. In states like Colorado, marijuana is surpassing alcohol in tax revenue, which helps funnel funding to schools and other important programs. But legalized marijuana also has a broader impact. Its effects can be felt Read the full article…

The Wink In Weed: Why Seattle Hempfest Is Still Worth Supporting

“There’s nothing in I-502 that allows a community to opt out,” Washington state Liquor Control Board spokesman Brian Smith said. If a marijuana retailer meets the state’s requirement for a license then it will be granted.

By David Rheins It’s been five years since Washington opened its legal cannabis marketplace, and today adult consumers in the Evergreen state have an abundance of high-quality, legal weed available in an impressive array of product configurations at affordable prices. Seattle Hempfest, taking place this week along the gorgeous Puget Sound, is the nation’s oldest and largest Read the full article…

FDA Approves First Cannabis-Based Epilepsy Drug

fda-logo

MARYLAND: The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from Read the full article…

Tilray Forms Strategic Alliance With Leading Pharmaceutical Company In Canada

Tilray_Logo

CANADA: Tilray, a federally licensed producer of medical cannabis, announced today that it has signed a binding letter of intent (LOI) to be the exclusive collaborator of a major pharmaceutical company to accelerate innovation and increase availability of high quality medical cannabis products. Through this LOI and the anticipated definitive agreements, Tilray is allied with Sandoz Read the full article…

America’s Drug Companies Are Bankrolling The Crusade Against Legal Weed

Although the government had initially been aiming for year-end, marijuana could start being sold from pharmacies in March.

As more U.S. states legalize marijuana, special interest groups that have a financial stake in the fight have been pushing back under the guise of fighting drug abuse. Last week, The Nation published an interesting look at who’s driving the fight against the legalization of marijuana. Pharmaceutical companies that make billions off painkillers and police unions are Read the full article…

Pharmaceutical Companies Don’t Want Marijuana Legalized

Lawmakers are moving ahead with legislative efforts to allow for the limited use of medical ‘cannabis’ while simultaneously forbidding anyone from either inhaling the herb or possessing its flowers.

I can see why pharmaceutical companies don’t want marijuana legalized. Take a $4 blood pressure pill with a glass of grapefruit juice, and you might get the effects of $1.75 of that medicine. Wow, with a whopping 47% of medicine ineffectiveness, it seems like a giant waste of money for a product that won’t do you any Read the full article…

Pharmaceutical Companies Don’t Want Marijuana Legalized

Why can’t we pile on the money for cancer research with marijuana! Regulating blood pressure with marijuana, halting mood swings and depression, the list gets longer every day!  The beneficial effects of this plant are just beginning to surface. With REAL research and development, this may just be the new “Super Drug” that will replace many of our older medications, the ones with vast side effects and contraindications. Even doctors agree some medications need to be retired.

I can see why pharmaceutical companies don’t want marijuana legalized. Take a $4 blood pressure pill with a glass of grapefruit juice, and you might get the effects of $1.75 of that medicine. Wow, with a whopping 47% of medicine ineffectiveness, it seems like a giant waste of money for a product that won’t do you any Read the full article…

NASP Launches Taskforce To Address Management Of Medical Marijuana

"Medical marijuana has come to the forefront of patient care in many of the diseases that Specialty Pharmacists treat including Multiple Sclerosis, Cancer, HIV and others,” Gary M. Cohen

VIRGINIA: The National Association of Specialty Pharmacy (NASP) has launched a taskforce to investigate the pharmacological management of medical marijuana, a growing issue for Specialty Pharmacists as the number of patients with chronic diseases continue to rise.